8 Panel CSI CLIA Screen In-Vitro Drug Test Cup, CLIA Waived, OTC, 25/Box
Brand : CSI™ Drug Test Cups
$77.50
- SKU:
- CSI-CUP-285T
CSI Cup - CLIA Screen In-Vitro 8-Panel CLIA Waived Drug Screening Test Cup
This high-quality CLIA-waived drug test cup is an easy, fast, qualitative, competitive binding immunoassay method for screening without the need for instrumentation.
The best-selling CSI Cup (CLIA Screen In-Vitro) Multi-Panel Drug Test Cup is a No Step, fully integrated, self-contained multi-drug screening cup. No tipping or turning required. Read results in 5 minutes. The cup is FDA Cleared and CLIA Waived. This cup is a fast visual, competitive panel immunoassay that can be used for the simultaneous, qualitative detection of multiple drug metabolites at specific cutoff levels in human urine.
Features & Benefits
- CLIA Waived
- Sold in boxes of 25 tests
- Includes "O-Ring seal" in cap for improved leak resistance
- New "Click Seal" cap - when you hear the “CLICK”, the cup is sealed, and the specimen is secured
- No step cup
- Up to 99% Accurate
- The dual-scale temperature strip verifies if the urine is "fresh" and not diluted
- Adheres to the SAMHSA Cutoff Levels
- Immediate Results
- Shelf-life up to 24 months
- New easy-to-open top for the confirmation lab
Download & Print Reference Materials
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Package Insert
CLIA Screen In Vitro Cup (CLIA Waived) Drug Test Instruction Sheet
| Eight Panel Configuration | ||
|---|---|---|
| Item Number | Drugs Tested | Regulatory Approvals |
| CSI-CUP-285T | AMP(1000), BUP(10), BZO(300), COC(300), OPI/MOP(300), MTD(300), OXY(100), THC(50) | FDA 510(k) Cleared CLIA Waived Health Canada Approved FDA Over the Counter Cleared (OTC) |
| SAMHSA Approved CLIA Waived Drug Panel Options | |||||
|---|---|---|---|---|---|
| Drug Name | Abbreviation | Cutoff Level | Minimum Detection Time in Urine* | Maximum Detection Time in Urine* | Calibrator |
| Amphetamine | AMP | 1000 ng/ml | 2-7 hours | 2-4 days | D-Amphetamine |
| Barbiturates | BAR | 300 ng/ml | 2-4 hours | 1-3 weeks | Secobarbital |
| Benzodiazepines | BZO / BZD | 300 ng/ml | 2-7 hours | 1-4 days | Benzoylecgonine |
| Buprenorphine | BUP | 10 ng/ml | 2-3 hours | 1 day | Buprenorphine |
| Cocaine | COC | 300 ng/ml | 1-4 hours | 2-4 days | Benzoylecgonine |
| Ecstasy | MDMA | 500 ng/ml | 1-3 days | 1-2 days | DL- Methylenedioxy-methamphetamine |
| Marijuana | THC | 50 ng/ml | 2 hours | up to 40 days | 11-nor-Δ9-THC-9 COOH |
| Methadone | MTD / MAD | 300 ng/ml | 3-8 hours | 1-3 days | Methadone |
| Methamphetamine | mAMP / MET | 1000 ng/ml | 2-7 hours | 2-4 days | D-Methamphetamine |
| Morphine | MOP / OPI-300 | 300 ng/ml | 2 hours | 2-3 days | Morphine |
| Opiates | OPI | 2000 ng/ml | 2 hours | 2-3 days | Morphine |
| Oxycodone | OXY | 100 ng/ml | 1-3 hours | 1-2 days | Oxycodone |
| Phencyclidine | PCP | 25 ng/ml | 4-6 hours | 7-14 days | Phencyclidine |
| Propoxyphene | PPX | 300 ng/ml | 1-2 days | N/A | Propoxyphene |
| Tricyclic Antidepressants | TCA | 1000 ng/ml | 8-12 hours | 2-7 days | Nortriptyline |
| * Detection times are not guaranteed. Reference configuration above for included drug panels. This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result. Gas Chromatography/Mass Spectrometry (GC/MS) is the preferred confirmatory method. Clinical consideration and professional judgment should be applied to any drug of abuse test result, particularly when preliminary positive results are indicated. | |||||
